Although GSDMA, GSDMB, and GSDME expression was not significantly correlated with glioma prognosis, it had significantly different levels in different clinical or molecular subtypes, suggesting that their potential value in glioma remains to be investigated. Here, GSDMB is linked to central nervous system cancer.